Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matti Aapro

Showing results (61-70 of 237) with videos related to

Pageof 24
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 9, 2018
Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years' Experience GainedMatti Aapro, Andriy Krendyukov, Martin Schiestl, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2005
Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?Ronald de Wit, Matti Aapro, Peter R Blower
Leukemia Research|April 22, 2019
Epoetin alfa for the treatment of myelodysplastic syndrome-related anemia: A review of clinical data, clinical guidelines, and treatment protocolsPere Gascón, Andriy Krendyukov, Nicola Mathieson, et al.
Breast (Edinburgh, Scotland)|August 17, 2011
Weekly nab-paclitaxel is safe and effective in ≥65 years old patients with metastatic breast cancer: a post-hoc analysisMatti Aapro, Sergei Tjulandin, Paul Bhar, et al.
Journal of Geriatric Oncology|March 1, 2021
Landmarks in geriatric oncologySilvio Monfardini, Lodovico Balducci, Janine Overcash, et al.
Cancer Medicine|August 4, 2023
Single-dose NEPA versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapyLaurent Zelek, Rudolph Navari, Matti Aapro, et al.
The Oncologist|September 21, 2011
Anemia management update: an international expert forum on blood transfusion and ESA use. Foreword, Matti Aapro, Pere Gascon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Supportive care considerations for older adults with cancerArash Naeim, Matti Aapro, Rashmi Subbarao, et al.
The Oncologist|May 23, 2024
Opioid metabolism and drug-drug interaction in cancerMatti Aapro, Stefano Fogli, Bart Morlion, et al.
European Journal of Haematology|November 25, 2017
MONITOR-GCSF DLBCL subanalysis: Treatment patterns/outcomes with biosimilar filgrastim for chemotherapy-induced/febrile neutropenia prophylaxisPere Gascón, Andriy Krendyukov, Nadja Höbel, et al.
Pageof 24

Showing results (61-70 of 237) with videos related to

Sort By:
Pageof 24
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 9, 2018
Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years' Experience GainedMatti Aapro, Andriy Krendyukov, Martin Schiestl, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2005
Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?Ronald de Wit, Matti Aapro, Peter R Blower
Leukemia Research|April 22, 2019
Epoetin alfa for the treatment of myelodysplastic syndrome-related anemia: A review of clinical data, clinical guidelines, and treatment protocolsPere Gascón, Andriy Krendyukov, Nicola Mathieson, et al.
Breast (Edinburgh, Scotland)|August 17, 2011
Weekly nab-paclitaxel is safe and effective in ≥65 years old patients with metastatic breast cancer: a post-hoc analysisMatti Aapro, Sergei Tjulandin, Paul Bhar, et al.
Journal of Geriatric Oncology|March 1, 2021
Landmarks in geriatric oncologySilvio Monfardini, Lodovico Balducci, Janine Overcash, et al.
Cancer Medicine|August 4, 2023
Single-dose NEPA versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapyLaurent Zelek, Rudolph Navari, Matti Aapro, et al.
The Oncologist|September 21, 2011
Anemia management update: an international expert forum on blood transfusion and ESA use. Foreword, Matti Aapro, Pere Gascon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Supportive care considerations for older adults with cancerArash Naeim, Matti Aapro, Rashmi Subbarao, et al.
The Oncologist|May 23, 2024
Opioid metabolism and drug-drug interaction in cancerMatti Aapro, Stefano Fogli, Bart Morlion, et al.
European Journal of Haematology|November 25, 2017
MONITOR-GCSF DLBCL subanalysis: Treatment patterns/outcomes with biosimilar filgrastim for chemotherapy-induced/febrile neutropenia prophylaxisPere Gascón, Andriy Krendyukov, Nadja Höbel, et al.
Pageof 24